Objectives : This study aims to estimate the oral antihyperglycemic medications adherence among ambulatory care with adult type 2 diabetes patients and to identify factors affecting the medication adherence in Korea. Methods : This study used the Korean National Health Insurance Database. Study population was 40,082 patients who were 20 years of age or older and first diagnosed with type 2 diabetes (ICD-10: E11) in 2004. The patients were followed up for two years in order to measure adherence with oral antihyperglycemic medications. The level of medication adherence was measured by the medication possession ratio (MPR). Results : The average MPR in the study population was 49.5%. The appropriate adherence rate (MPR$\geq$80%) was 29.4% and showed variation according to the characteristics of individual patients. Multiple logistic regression analysis revealed that the odds of appropriate adherence increased with female (OR:1.21, CI:1.14-1.27), older age, increasing ambulatory care visits, health insurance (OR:1.53, CI:1.33-1.76), decreasing ambulatory care providers, using a specialized general hospital as their main attending medical institution (OR:10.08, CI:8.96-11.33), having co-morbidity, using polytherapy (OR:1.07, CI:1.01-1.13). Conclusions : The medications adherence for patient with type 2 diabetes is low in Korea, and shows variation according to the characteristics of patients. For proper management of diabetes, health care policy is expected to be enacted to improve medications adherence continuously. In particular, more intensive management is needed for patients with low medications adherence. Also, health care policy makers need to develop the program to induce health care utilization by a patient to be more concentrated with the same provider.
Agency for Healthcare Research and Quality. Diabetes care quality improvement : A resource guide for state action. AHRQ;2004. Available from : http://www.qualityindicators.ahrq.gov
American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2004 ; 27(1) : S15-35.
Balkrishnan R, Rajagopalan R, Camacho FT, Huston SA, Murray FT, Anderson RT. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus : a longitudinal cohort study. Clin Ther 2003 ; 25(11) : 2958-2971.
Center for Chronic Disease Preventive and Control : Diabetes in Canada. Health Canada. CDC ; 2002.
Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care 2004 ; 27(5) : 1218-1224.
DiMatteo MR. Variations in patients' adherence to medical recommendations : a quantitative review of 50 years of research. Med Care 2004 ; 42(3) : 200-209.
Duncan JC, Rogers R. Medication compliance in patients with chronic schizophrenia : implications for the community management of mentally disordered offenders. J Forensic Sci 1998 ; 43(6) : 1133-1137.
Gary TL, Crum RM, Cooper-Patrick L, Ford D, Brancati FL. Depressive symptoms and metabolic control in African-Americans with type 2 diabetes. Diabetes Care 2000 ; 23(1) : 23-29.
Gill JM, Mainous AG 3rd, Diamond JJ, Lenhard MJ. Impact of provider continuity on quality of care for persons with diabetes mellitus. Ann Fam Med 2003 ; 1(3) : 162-170.
Hearnshaw H, Lindenmeyer A. What do we mean by adherence to treatment and advice for living with diabetes? A review of the literature on definitions and measurements. Diabet Med 2006 ; 23 : 720-728.
Hertz RP, Unger AN, Lustik MB. Adherence with pharmacotherapy for type 2 diabetes : a retrospective cohort study of adults with employer-sponsored health insurance. Clin Ther 2005 ; 27(7) : 1064-1073.
Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, Magid DJ. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med 2006 ; 166(17) : 1836-1841.
International Diabetes Federation. Diabetes Atlas, 2nd edition ; 2003.
Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC. An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients. Med Care 2008 ; 46(11) : 1125-1133.
Lau DT, Nau DP. Oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes. Diabetes Care 2004 ; 27(9) : 2149-2153.
McCombs JS, Nichol MB, Newman CM, Sclar DA. The costs of interrupting antihypertensive drug therapy in a Medicaid population. Med Care 1994 ; 32(3) : 214-226.
Schectman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care 2002 ; 25(6) : 1015-1021.
Shah NR, Hirsch AG, Zacker C, Taylor S, Wood GC, Stewart WF. Factors associated with first-fill adherence rates for diabetic medications : a cohort study. J Gen Intern Med 2009 ; 24(2) : 233-237
Skaer TL, Sclar DA, Markowski DJ, Won JK. Effect of value-added utilities on prescription refill compliance and Medicaid health care expenditures - a study of patients with non-insulin-dependent diabetes mellitus. J Clin Pharm Ther 1993 ; 18(4) : 295-299.
Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005 ; 43(6) : 521-530.
The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993 ; 329(14) : 977-986.
UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998 ; 352(9131) : 854-865.
Wagner EH, Sandhu N, Newton KM, McCulloch DK, Ramsey SD, Grothaus LC. Effect of improved glycemic control on health care costs and utilization. JAMA 2001 ; 285(2) : 182–189.
이 논문을 인용한 문헌 (1)
Cho, Su-Jin ; Chung, Seol-Hee ; Oh, Ju-Yeon 2011. "Differences between Diabetic Patients' Tertiary Hospital and Non-tertiary Hospital Utilization According to Comorbidity Score" 보건행정학회지 = Korean journal of health policy and administration, 21(4): 527~540